Keyphrases
Systemic Sclerosis
100%
Rheumatoid Arthritis
100%
Pharmacological Targets
100%
Systemic Lupus Erythematosus
100%
CD38
100%
NADase
100%
Nicotinamide Adenine Dinucleotide (NAD+)
55%
Systemic Lupus Erythematous
44%
Enzymatic Activity
22%
Rheumatologic Diseases
22%
Human Disease
11%
Potential Therapeutics
11%
Cell-type Specificity
11%
Homeostasis
11%
Metabolism
11%
Targeted Treatment
11%
Preclinical Data
11%
Dysregulated
11%
Increased Activity
11%
Increased Vulnerability
11%
Catabolism
11%
Plasma Cells
11%
Metabolic Tissues
11%
Structural Role
11%
Human Data
11%
Systemic Fibrosis
11%
Potential Side Effects
11%
Anti-CD38 Antibody
11%
Tissue Dysfunction
11%
Metabolic Imbalance
11%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Sclerosis
100%
Rheumatoid Arthritis
100%
Nicotinamide Adenine Dinucleotide Nucleosidase
100%
Systemic Lupus Erythematosus
100%
Inflammatory Arthritis
100%
Nicotinamide Adenine Dinucleotide
100%
Diseases
60%
Infection
20%
Side Effect
20%
Fibrosis
20%
Immunology and Microbiology
Inflammatory Arthritis
100%
Systemic Lupus Erythematosus
100%
Systemic Scleroderma
100%
CD38
100%
Enzyme Activity
20%
Homeostasis
10%
Immunoglobulin Producing Cell
10%